For example, the PDE4 inhibitor roflumilast was the first developed treatment for specific phenotypes of chronic obstructive pulmonary disease (COPD) [4], and the PDE5 inhibitor sildenafil is an orally effective therapy for the treatment of males with erectile dysfunction (ED) [5]. Here, PDE5A is linked to chronic obstructive pulmonary disease.